$MNKD Headlines Skullcandy gains on upgrade,Tesla

New Post Public Reply Private Reply Replies (0) Message Board

Oct 30, 2014 at 10:22 AM

$MNKD Headlines

Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen

MannKind: What The Market's Implying, And Why It's Wrong. 8:18 a.m. Today - Seeking Alpha
MannKind: What To Expect From Earnings 11:20 a.m. Oct. 29, 2014 - Seeking Alpha
How MannKind Long Investors Can Profit From Short Raids 8:52 a.m. Oct. 28, 2014 - Seeking Alpha
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 28, 2014 - Zacks.com
MNKD: 17 Weeks and 58% Later, MannKind Stock FINALLY Is a Buy 7:15 a.m. Oct. 28, 2014 - InvestorPlace.com
Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes 4:16 a.m. Oct. 28, 2014 - Seeking Alpha
Biotech Short Interest Becomes Stock Specific 9:47 a.m. Oct. 27, 2014 - 247WallSt.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC MNKD CTEL 5:45 a.m. Oct. 27, 2014 - InvestorPlace.com
MannKind: Massive Short Interest Could Lead To Big Gains 3:28 p.m. Oct. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Turbulence At Boeing (10/23/14) 5:43 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
MannKind Corporation Stock: Unloved and Unbelievably Attractive 7:42 a.m. Oct. 23, 2014 - InvestorPlace.com
FDA accepts Lilly's NDA for type 2 diabetes combo 10:52 a.m. Oct. 21, 2014 - Seeking Alpha
Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade 12:46 p.m. Oct. 20, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More 7:46 a.m. Oct. 20, 2014 - 247WallSt.com
5 Stocks With Poor Sales Growth — HTS MITT UEC MNKD CTEL 4:30 a.m. Oct. 20, 2014 - InvestorPlace.com
MannKind: 5 Potential Technosphere Applications 8:38 a.m. Oct. 18, 2014 - Seeking Alpha
Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party 8:16 a.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape 9:46 a.m. Oct. 16, 2014 - Zacks.com

Insider Trading Buzz for Twitter, Delta Air Lines, Apple, GoPro, GT Advanced Technologies, and MannKind 8:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014 5:00 p.m. Oct. 27, 2014 - GlobeNewswire
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 8:45 a.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Alibaba, Yahoo!, El Pollo Loco and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 8:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Intel, MannKind, GoPro, Plug Power, and Cliffs Natural Resources 8:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Latest Insider Trading for FuelCell Energy, Flextronics, MannKind, GT Advanced Technologies, Plug Power, and GoPro 8:55 a.m. Oct. 15, 2014 - PR Newswire - PRF
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 9:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Free Earnings Forecast for GoPro, Glu Mobile, Frontier Communications, Plug Power, Cliffs Natural Resources, and MannKind 8:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Insider Trading Research for CareFusion, Arch Coal, Netflix, Cliffs Natural Resources, MannKind, and Plug Power 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Insider Trading Alerts for Comcast, RF Micro Devices, Broadcom, GoPro, MannKind, and Yahoo 8:55 a.m. Oct. 3, 2014 - PR Newswire - PRF
MannKind Announces Receipt of $150 Million Licensing Upfront Payment 7:30 p.m. Sept. 29, 2014 - GlobeNewswire
Insider Trading Reports for Apple, Cisco, Yahoo, Tesla, MannKind, and Bank of America 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Insider Trading Alerts for Facebook, Apple, Cisco, Verizon, MannKind, and Tesla Motors 8:55 a.m. Sept. 26, 2014 - PR Newswire - PRF
MannKind Announces Closing of Global Licensing Agreement With Sanofi 5:00 p.m. Sept. 24, 2014 - GlobeNewswire
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:00 p.m. Sept. 2, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

transcosmos Boosts Supply Chain with AI-Powered Tools

No-Nonsense Supply Chain Evolution at transcosmos Take a hard look at the chaos flying around the supply chain arena these days. It's like every time you turn your head, there's a new twist landing folks into deeper complexity. Look, if you thought supply chain management was a snooze of a topic, think again because transcosmos just dialed up the intensity with its...

BCD Travel Faces Class Action Probe After Data Breach

Class Action Stirred by BCD Travel Data Breach Here's the scoop, folks: Edelson Lechtzin LLP, a heavyweight in the world of class action law firms, is sniffing around BCD Travel Services B.V. over a juicy data breach that left about 700,000 traveler records flapping in the wind. Grab your coffee—this one's got all the trimmings of a modern-day digital fiasco. The Breach...

Shareholder Stakes at Risk in Major Mergers

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Pakistani Banks Flunk Climate Pledge Test by Wide Margin

Pakistani Banks' Sustainability Scores: Hitting Rock Bottom Here's the deal: seven major commercial banks in Pakistan have just been called out, and not for anything good. There's this latest assessment from Fair Finance Pakistan, launched on October 13, 2026, that's slashing their climate and biodiversity numbers to bits. We're talking an embarrassing average score of...

Sodium-Ion Tech Showcased by Aeson Power in Melbourne

A Shock to the System: Sodium-Ion's Rising Star If you're tired of hearing about lithium, Aeson Power just gave us a much-needed jolt at All Energy Australia 2026. This isn't just some new fad—they've proven the real-world chops of sodium-ion technology across energy storage and automotive platforms. At the Melbourne show, they laid out their goods, showing how this...

How Dental Cleaning Frequency Boosts Oral Health

Cleaning Up Confusion on Dental Visits Never thought I'd be waxing poetic about gum health, but here we are. You know what they say, ain't no business like show business—and today's show is all about the pearly whites context, courtesy of Dr. Calvin Despain over in Moses Lake, Washington. Apparently, keeping that grin free from plaque isn't as simple as a quick brush...

Home Selling in Henderson County: Tips from Experts

An Insider's View on Selling Homes in Henderson County Ace up, folks—selling a home isn't child's play. Courtney Robertson, a seasoned real estate expert, lays out the bare truth about what sellers need to know when putting their property on the market in Henderson County, Texas. This isn’t just about slapping on paint and praying for buyers. Nope, there's a lot more...

Legacy of Professor Raymond Yukna: A Laser Pioneer

End of an Era in Periodontology For those of us who have a stake in the world of dental technology, today hangs heavy. We talk about innovators, pioneers, and game-changers all the time, but Dr. Raymond A. Yukna wasn't just another name on that list - he was the list. The guy practically wrote the book on modern periodontal therapy. With his passing, we're not just saying...

FirstEnergy Pumps $115K into PA Housing Stability

Bankrolling Hope: FirstEnergy's $115K Commitment On the surface, corporate philanthropy sounds like yet another PR stunt, but sometimes these dollars pour a lifeline for those in dire need. Today, we look at FirstEnergy Foundation throwing a weighty $115,000 towards ensuring Pennsylvanians have stable roofs over their heads. This isn't your garden-variety donation—a lot...

Lecanemab's New Data: What Investors Should Monitor

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...